RA | Controls | |
---|---|---|
Data are mean (SEM) or mean (range)*. | ||
NSAIDs, non-steroidal anti-inflammatory drugs; DMARDs, disease modifying drugs. | ||
Number of subjects | 15 | 14 |
Age (years) | 41.2 (1.5) | 44 (2.8) |
Body mass index (kg/m2) | 21.6 (1.1) | 23 (1.1) |
Disease duration (years) | 8.2 (2.4) | – |
Number of affected joints | 5.1 (2–10)* | – |
Morning stiffness (min) | 36 (0–120)* | – |
Radiographic changes (Steinbrocker’s criteria) | 2.3 (1–3)* | – |
Erythrocyte sedimentation rate (mm/1st h) | 20.3 (12) | – |
C reactive protein (mg/l) | 15.4 (13) | – |
Rheumatoid factor (IU) | 936 (16–5120)* | – |
Number of patients using NSAIDs | 15 | – |
Number of patients using methotrexate | 10 | – |
Number of patients using DMARDs | 12 | – |